In Case You Haven’t Heard
05/09/2023
FDA’s Regulation of OTC Hearing Aids vs. PSAPs Last fall, FDA released its final rule establishing a regulatory category for Over-the-Counter (OTC) hearing aids, pursuant
FDA’s Regulation of OTC Hearing Aids vs. PSAPs Last fall, FDA released its final rule establishing a regulatory category for Over-the-Counter (OTC) hearing aids, pursuant
No! FDA Reminds Consumers that Hand Sanitizers are Regulated as Over-the-Counter Drugs With new marketing of hand sanitizers touting food flavors or fragrances, FDA
FDA Issues Draft Guidance on Format and Content of OMOR Submissions: OTC Drug Reform and The CARES Act This week, FDA announced that it issued
This week, FDA kicked-off a new resource about the Modernization of Cosmetics Regulation Act of 2002 (MoCRA) and a follow-up constituent advisory that FDA has
Marketing Sunglasses, Bandages, Hospital Equipment, Pregnancy Test Kits, Cosmetic Devices, Personal Lubricants and More The U.S. leads the world in medical innovation and is the
Protecting Consumers, Limiting Supply Chain Disruption and Avoiding Business and Reputation Damage Quickly and Effectively With product recalls consistently being in the news over undeclared
While the year is winding down, FDA remains active in enforcement and issuing new guidance. Here’s a look at what has been happening at the Agency.
In Multi-Company Warning Letters Issued to Dietary Supplement Companies. FDA Issues Seven Warning Letters to Dietary Supplements Claiming to Treat Cardiovascular Disease.
A reminder to register or renew your food, dietary supplement, OTC drug, or medical device facility registration before December 31, 2022
